Table 1.
Case (year of publication) [reference] |
Age (years)/sex | Prevotellaspecies | Identification method | Underlying conditions and/or risk factors | Possible source of infection | Clinical manifestations | CRP (mg/L) | Treatment | Outcome |
---|---|---|---|---|---|---|---|---|---|
1 (2013) [2] | 17/M | Prevotellaspp | PCR (16S rRNA) | NR | NR | Fever, cough, chest pain | NR | Antibiotics + drainage | Cure |
2 (2015) [5] | 76/M | Prevotellaspp | PCR (16S rRNA) | DM | NR | Fever, chest pain | 147.4 | Antibiotics + drainage | Cure |
3 (2018) [3] | 88/M | Prevotelladentalis | MALDI-TOF MS PCR (16S rRNA) |
CRD DM |
Lung | Chronic pleural effusion | 194.1 | Antibiotics + drainage | Died |
4 (2020) [5] | 42/M | Prevotellaoris | NR | DM | Lung | Chest pain, left upper limb weakness, cough | 399 | Antibiotics + drainage | Cure |
5 (2021) [6] | 12/M | Prevotellapleuritidis | Next-generation sequencing-based clinical metagenomics | DM | Lung | Fever, cough, chest pain, dyspnea | NR | Antibiotics + drainage | Cure |
6 (2021) [7] | 49/M | Prevotellaspp | PCR (16S rRNA) | NR | Lung | Asthenia, fever, weight loss, dyspnea | 87.5 | Antibiotics + thoracoscopic surgery | Cure |
7 (2022) [PR] | 60/M | Prevotellaoris | MALDI-TOF MS PCR (16S rRNA) |
Mediastinitis | Lung | Chest pain, general malaise, vomiting | Normal | Antibiotics + drainage | Died |
8 (2022) [PR] | 47/F | Prevotelladenticola | MALDI-TOF MS PCR (16S rRNA) |
Autoimmune disease | NR | Drowsiness, inhability to emit language | 42.7 | Antibiotics + drainage | Cure |
M: male; F: female; NR: not reported; CRP: C-reactive protein; PR: present report; DM: diabetes mellitus; CRD: chronic respiratory disease.